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Abstract The highly compact nature of the pu¡er¢sh (Fugu
rubripes) genome renders it a useful tool not only for annotating
coding regions within vertebrate genomes, but also for the iden-
ti¢cation of sequences important to gene regulation. Indeed,
owing to this compaction it will be feasible in many instances
to initiate analyses using entire intergenic regions when mapping
gene promoters; a strategy that is very rarely feasible with the
expanded genomes of other species. Stemming from our interest
in studying promoters expressed in chondrocytes, we selected for
study the intergenic region upstream of Fugu 3P-phosphoadeno-
sine 5P-phosphosulfate synthase 2, fPapss2, a gene required for
the normal development of cartilage extracellular matrix. Func-
tional characterization of the entire fPapss2 5P intergenic region
was carried out by monitoring expression of the enhanced green
£uorescent protein (EGFP) gene reporter in the developing car-
tilage of transgenic Xenopus laevis. By evaluating a series of 5P
intergenic region deletions we de¢ned a minimal fPapss2 se-
quence of V300 bp that was essential for EGFP expression
in tadpole cartilage. This functional analysis of an entire Fugu
intergenic region, combined with the e⁄ciency of Xenopus
transgenesis, serves as a model for the rapid characterization
of evolutionarily-conserved regulatory regions of other pu¡er¢sh
genes.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
By virtue of its approximately 380 Mb size, the genome of
the pu¡er¢sh, Fugu rubripes, is amongst the most compact of
vertebrate genomes. Despite its compact nature, however, the
Fugu genome encodes a gene repertoire similar in scope to
that of other vertebrates, including humans [1,2]. Thus, the
overall gene density in the Fugu (one gene/12 kb) is almost an
order of magnitude higher than that of mammalian genomes
(one gene/100 kb). The compaction of the Fugu genome, due
for the most part to the evolutionary depletion of repetitive
elements and other non-essential DNA sequences that are
found in the vast majority of vertebrates, has occurred pri-
marily at the expense of intronic sequences and intergenic
regions. As an example of the latter, the intergenic segments
upstream of the fPten, fMinpp1, and Fugu 3P-phosphoadeno-
sine 5P-phosphosulfate synthase 2 (fPapss2) genes are 6 2.5
kb in length [3]. As a result of these attributes, the Fugu ge-
nome has been proposed as a reference point to aid not only
in the discovery of novel genes and the elucidation of the
exon^intron structure, but also in the identi¢cation of regu-
latory elements that control gene expression [1].
The compact promoter regions of Fugu have been shown
capable of faithfully recapitulating the complex expression
patterns of mammalian genes, both in mammalian cell lines
and transgenic rodents [4^10], indicating that key cis elements
required for mediating expression can be conserved between
¢shes and mammals. Comparative analyses of Fugu and hu-
man/mouse promoter regions are useful in identifying con-
served non-coding sequences. Such conserved sequences rep-
resent strong candidates for potential regulatory elements
[4,6,8,11^14], and can be easily validated through transgenic
or cell culture systems. Since the intergenic regions are often
remarkably short in Fugu, the entire intergenic region can
often be easily ampli¢ed by polymerase chain reaction
(PCR) for use in expression studies. The recent completion
of the draft sequences of mammalian and pu¡er¢sh [2] ge-
nomes has provided an unprecedented opportunity to study
the regulation of vertebrate genes by the comparative ge-
nomics approach.
Owing to an interest isolating gene promoters that are
highly expressed in chondrocytes, we initiated an analysis of
the 5P region of the fPapss2 gene. The enzyme encoded by this
gene, PAPSS2, is required for the sulfation of many molecular
species, including large extracellular matrix macromolecules
such as the proteoglycans of cartilage [15]. For this reason,
Papss2 has a critical role in normal vertebrate cartilage and
skeletal development [15,16]. Indeed, attesting to its impor-
tance, mutations of Papss2 orthologs are responsible for mu-
rine brachymorphism (bm) as well as a human disorder, spon-
dyloepimetaphysial dysplasia, ¢rst described in a Pakistani
kindred [15,17^20]. Transcripts derived from the human
PAPSS2 gene, also known as HSK2 [20], while abundant in
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cartilage, are also present at varying levels in a variety of
other tissues. These included adult liver, lung, placenta, ovary,
peripheral blood lymphocytes, adrenal gland, skin, and heart
[16,21]. In a study to characterize Fugu Pten, the fPapss2
ortholog was identi¢ed [3], making possible a search for func-
tional promoter activity within the 5P intergenic region of this
gene.
This study, therefore, focused on evaluating the fPapss2 5P
intergenic region for its ability to direct expression of the
enhanced green £uorescent protein (EGFP) reporter gene to
the developing cartilage of transgenic Xenopus laevis tadpoles.
X. laevis, a well-established model system for developmental
studies, represents a powerful tool for analyses of in vivo gene
regulation using transgenes to direct the expression of £uores-
cent proteins. The latter are readily visualized within tissues of
interest owing to the transparent nature of Xenopus tadpoles.
2. Materials and methods
2.1. Generation of transgenic X. laevis
Xenopus adults were maintained in accordance with University of
Calgary guidelines for animal care. Sperm nuclei were prepared ac-
cording to the method of Amaya and Kroll [22], with the modi¢ca-
tions of Sparrow et al. [23]; that is, protease inhibitors were not used,
and digitonin (ICN Biomedicals) was used in place of lysolecithin to
release sperm nuclei. Sperm were then diluted to 1U105 nuclei/Wl with
sperm storage bu¡er [22], and aliquots snap-frozen in liquid nitrogen
prior to storage at 380‡C. For microinjection, nuclei were thawed
and prepared by mixing 2.5 Wl (2.5U105 nuclei) with equimolar
amounts of each plasmid construct as described [22]. Following 10
min incubation at room temperature, the nuclei^plasmid mixture was
diluted to 500 Wl with sperm dilution bu¡er [22] with gentle mixing.
Injection needles were ‘back-loaded’ with the reaction mixture in
preparation for microinjection, and then nuclear transplantation was
performed according to the method of Sparrow et al. [23].
2.2. Transgene construct production
The complete 5P intergenic region of fPapss2 was ampli¢ed by PCR
using a Fugu cosmid, #141O7 (Greg Elgar’s cosmid library, HGMP-
RC, UK), as the template [3] with the forward (gctgcttttaaccagcctg),
and reverse (tctctcgactcgaaggcg) primers, which also introduced BglII
and HindIII sites, respectively. The 1725 bp ampli¢ed product was
then cloned into the BglII and HindII sites of the pEGFP-1 vector
(Clontech). fPapss2 promoter constructs having progressive 5P dele-
tions were generated using the following forward primers, which also
introduced a HindIII restriction site: 1218 bp, gagagggtgctccaatgtg-
gaac; 788 bp, gggcacaggacattagatacg; 436 bp, cgtctttgaacctctggccg;
349 bp, cttgcttcaaatcctccgcagcag; 224 bp, gaaccattggctgttggaaag; 81
bp, ggcctcagtcgagcagaactttcgg. The same reverse primer, 5P-ggagg-
tctggctattggatggg, consisting of sequences 332 to 353 bp upstream
of the translation initiation codon and which also introduced a KpnI
site, was used in all the ampli¢cations. Individual PCR products were
cloned into the pEGFP-1 vector following digestion of this plasmid
with HindIII and KpnI. Plasmids containing the 1.2, 0.79 and 0.44 kb
5P fPapss2 sequences in pEGFP-1 were linearized by digestion with
StuI prior to microinjection. For those containing the 1.73, 0.35, 0.22,
and 0.08 kb 5P fragments the plasmids were cut with A£II and StuI
digestion and then agarose gel electrophoresis was used to remove a
plasmid fragment containing the SV40 promoter, neomycin resistance
cassette. The enhancer elements within this promoter have the poten-
tial for altering expression of promoter fragments as we found in the
case of the 0.22 and 0.08 kb fragments, where variable EGFP expres-
sion was seen in the transgenic tadpoles (data not shown). A pro-
moter-less pEFGP-1 vector was used as a negative control. The Xen-
opus cardiac actin gene promoter, designated XCAR, that generates
DsRed expression in developing tadpole muscle, was generously pro-
vided by E. Amaya (University of Cambridge).
2.3. Imaging of EGFP in live tadpoles
Tadpoles were screened for transgene expression using a Zeiss M2-
BIO microscope ¢tted with a GFP ¢lter set. Transgenic tadpoles were
anesthetized in benzocaine, and images of £uorescent tadpoles were
captured and processed using Openlab 3.1.5 (Improvision).
3. Results and discussion
Transgenic tadpoles were examined for EGFP expression
directed by the entire 5P intergenic region of the fPapss2
gene, a 1.73 kb sequence that extends from the polyadenyla-
tion signal of the upstream fMinpp1 gene to a site V30 bp
upstream of the translation initiation codon of fPapss2 [3].
Examination of the resultant founders revealed strong
EGFP signals within the cartilage of transgenic tadpoles,
with the highest levels of EGFP ¢rst being present in the
developing chondrocranium of early stage tadpoles (Fig.
1A), and subsequently, within the various cartilaginous tissues
of the developing limbs of metamorphosing tadpoles (see be-
low). To further isolate the promoter region of fPapss2 re-
quired for expression of EGFP in the chondrocranium, and
hence to localize the region(s) containing key regulatory ele-
ments for tadpole chondrocyte expression, progressive 5P de-
letions of the 1.73 kb intergenic fragment were obtained by
PCR (Fig. 2) and subcloned into the pEGFP-1 plasmid. Loss
of EGFP expression was seen between the 0.35 and the 0.22
kb segments (Fig. 2). However, since the expression pattern
right up to the stage 58 tadpole was identical to that of trans-
genic tadpoles generated using the 1.73 kb segment, we con-
cluded that all the cis-acting elements required for chondro-
cyte expression up to this developmental stage were intact
Fig. 1. The fPapss2 1.73 kb 5P intergenic region (A) and a 0.35 kb 5P segment (B) are both able to direct expression of EGFP (green signal) to
the developing cartilage of transgenic tadpoles. The two images are cephalic halves of representative stage 51 animals demonstrating strong
EGFP expression in the chondrocranium (CC), gill arch cartilage (C) and nasal cartilage (NC). The position of the developing brain is indi-
cated by a white dotted line. Both specimens have been rotated on their longitudinal axis to expose the left half of the chondrocranium directly
underlying the brain. The signals in the lens of the left eye (E) and pronephros (PN), also seen in control tadpoles, are due to auto£uores-
cence.
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within the 0.35 kb fragment (Fig. 1B). Likely due to integra-
tion in the vicinity of an endogenous enhancer, tadpoles gen-
erated from the 0.22 and 0.08 kb fragments occasionally dem-
onstrated low levels of EGFP expression (data not shown),
however, the vast majority of embryos microinjected with
either of these two transgenes failed to generate detectable
EGFP signals.
Demonstrating that the fPapss2 promoter was most highly
expressed in tadpole cartilage, and also that EGFP signal
intensity was not simply a function of the cell density of
any given tissue, a vector encoding the red £uorescent protein,
DsRed, under the control of a Xenopus muscle-speci¢c gene
promoter, XCAR [24], was co-injected with the fPapss2
EGFP plasmid. As seen in the representative double trans-
genic tadpoles shown in Figs. 3 and 4, the fPapss2 pro-
moter-directed expression of EGFP primarily to cartilaginous
tissue, possibly with some overlap with XCAR expression at
speci¢c sites, such as the tail and oral musculature of stage 55
tadpoles (Figs. 3A^C and 4). While the fPapss2 promoter did
not lead to detectable EGFP signals in developing abdominal
wall muscle ¢bers (Fig. 3A^C), EGFP signals in the tail region
may have been due coexpression of EGFP and DsRed in
muscle cells. However, it is possible that the EGFP expression
in tails was due to the presence of chondrocytes. DsRed-ex-
pressing muscle bundles (which also expressed low levels of
EGFP) in the stage 55 hindlimb were clearly separable from
EGFP-positive cartilaginous rudiments (Fig. 3F).
fPapss2 (1.73 kb) segment-directed EGFP expression was
seen in the cartilage right up to the stage 58, and was clearly
evident in the developing interphalangeal joints of the hind-
foot (Fig. 5A). Older animals, as they neared metamorphosis,
tended to show reduced EGFP signals, owing in part to di-
minished skin transparency and the increased presence of mel-
anin-containing cells. Interestingly, EGFP signals appeared in
the region of the bony sheath that forms in the mid-portions
of femur and tibia in stage 58 tadpoles (Fig. 5), suggesting
that fPapss2 promoter might be directing EGFP expression to
osteoblasts, perhaps during the process of endochondral ossi-
¢cation when much new extracellular matrix is being laid
down. EGFP signals were also present in other tissues of
the hindlimb, including skin and developing muscle bundles
(Fig. 5B). Adult human muscle was previously reported as
being negative for PAPSS2 expression [21], thus the fact we
saw it in the tadpoles may be indicative of a unique feature of
the Fugu gene promoter fragments we tested. However, it is
also possible that PAPSS2 expression is developmentally
regulated, and that this gene is expressed in the human em-
bryonic muscle. Despite evidence of PAPSS2 expression in
adult mammalian liver and heart [16,21] we did not see
EGFP in these sites in tadpoles. Perhaps adult frogs would
show expression at these sites. It is also possible that EGFP
was expressed in tadpole heart and liver, but at reduced levels.
EGFP is a relatively insensitive reporter of gene activity, par-
ticularly as compared with reporters detected by virtue of
their enzymatic activity, such as L-galactosidase. Finally, it
is conceivable that the ¢sh promoter is not capable of fully
recapitulating the expression pattern of mammalian PAPSS2
gene. Further investigation will be required to clarify these
various questions.
Both the 1.73 and 0.35 kb intergenic 5P segments resulted in
Fig. 2. Successive deletions of the fPapss2 5P intergenic region were
evaluated for their ability to direct expression of EGFP in transgen-
ic tadpoles. Sequence coordinates were from the Fugu Pten locus se-
quence (GenBank accession number AF325922) [3]: complete inter-
genic region (from region of fMinpp1 polyadenylation signal to start
of fPapss2) 1.73 kb, bp 46 272^47 998; 1.22 kb, bp 46 302^47 520;
0.79 kb, bp 46 302^47 090; 0.44 kb, bp 46 302^46 738; 0.35 kb, bp
46 302^46 651; 0.22 kb, bp 46 302^46 526; 0.08 kb, bp 46 302^46 383.
Chart shows 5P fPapss2 segments that were capable of directing
EGFP expression to developing cartilage in transgenic tadpoles. Re-
sults were derived from examination of the EGFP expression pat-
terns in s 25 founders produced for each of the 1.2, 0.79, 0.44 kb
5P fPapss2 sequences, and s 50 founders for each of the 1.73, 0.35,
0.22, and 0.08 kb 5P fPapss2 sequences.
Fig. 3. Coexpression of EGFP, and DsRed under the control of
fPapss2 (1.73 kb) and XCAR promoters, respectively, following co-
microinjection of the two transgenes. A: fPapss2-directed EGFP ex-
pression within hindlimb (HL) cartilages and proximal tail chondro-
cytes and/or musculature (TM) of a representative stage 55 trans-
genic tadpole. B: XCAR promoter-directed DsRed expression is
present within tail musculature (TM), rectus abdominus muscle ¢-
bers (RA), and leg muscles of the same tadpole. C: Overlay of red
and green £uorescence in the above regions, with yellow signifying
coexpression of both reporters in the same tissue. D: EGFP expres-
sion in the cartilaginous femoral and tibial bone precursors (C) of
the developing hindlimb, as well as in the primordial digits (asterisk)
of a representative stage 55 transgenic tadpole. E: DsRed expression
reveals XCAR promoter activity clearly de¢ning the major muscle
bundles (MB) of the developing hindlimb in the same specimen.
F: Overlay of red and green £uorescence showing EGFP- and
DsRed-expressing structures in relation to one another.
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a high frequency of founders, with approximately 80% of
developing embryos proving ‘positive’ for transgene expres-
sion (data not shown). Furthermore, all resulting tadpoles
generated with both 5P fragments exhibited comparable
EGFP signal intensities and tissue-speci¢c expression patterns,
suggesting relative independence of the fPapss2 regulatory
elements from so-called chromatin ‘position e¡ects’ or varie-
gated patterns of expression that can be seen in transgenic
animals [25]. It should be noted that in this study we con¢ned
our analyses to the 5P intergenic region of the fPapss2 gene,
and we have therefore not excluded the possibility that regu-
latory elements, such as enhancers, silencers, and locus control
regions, capable of regulating fPapss2 gene expression exist
outside the con¢nes of the region that we evaluated in trans-
genic tadpoles.
In order to identify putative binding sites for known tran-
scription factors within this region, we analyzed the fPapss2
0.35 kb promoter region using AliBaba2.1. This program
identi¢ed six potential Sp1 binding sites, in addition to one
of each of the following (amongst others) : YY1, AP-1,
C/EBPalpha and C/EBPdelta. Interestingly, the proximal
2 kb of the human PAPSS2 (HSK2) promoter contains nine
potential Sp1 and one AP-1 binding sites [20], suggesting that
these transcription factors may play a role in the regulation of
Papss2 genes in vertebrates. Interestingly, a comprehensive
mutational analysis of the human PAPSS2 promoter revealed
the importance of two transcriptional start site proximal Sp1
sites to promoter activity (using the luciferase reporter) in
transiently transfected HeLa and SW13 cells [26]. Given that
Sp1 and AP-1 are ubiquitously expressed, it is unlikely that
they determine the relatively cartilage-speci¢c expression pat-
tern of the fPapss2 promoter in transgenic tadpoles, although
combinatorial interactions of these transcription factors with
some novel tissue- and/or stage-speci¢c transcription factor(s)
in chondrocytes cannot be excluded.
To attempt to identify conserved potentially novel cis-act-
ing elements that might mediate cartilage-speci¢c expression,
we compared 0.35 kb fPapss2 promoter with the proximal 2 kb
of the human PAPSS2 promoter using the program Pipmaker
(http://bio.cse.psu.edu/pipmaker). This analysis did not reveal
any conserved elements that were shared between the Fugu
and human promoters. It should be noted that many cis-act-
ing elements consist of very short sequences (6^10 bp) with
varying degrees of degeneracy across species [27]. It is, there-
fore, likely that the programs we employed may have failed to
identify novel functional cis elements within the Fugu and
human Papss2 promoters. Further characterization of the
compact fPapss2 through nuclear extract binding assays and
deletions/mutations of putative transcription factor binding
sites, followed by expression studies in transgenic Xenopus
Fig. 4. The Fugu Papss2 0.35 kb 5P intergenic region directs expres-
sion of EGFP primarily to cartilage (green signal). XCAR-directed
DsRed expression is seen in muscle. The image is of the cephalic
half of representative stage 51 transgenic tadpole, demonstrating
DsRed signals in all muscle tissues, including the delicate extraocu-
lar muscles (indicated by asterisks), as well as the oral (OM) and
tail musculature (TM). EGFP (green) expression can be seen pri-
marily in chondrocyte-rich sites, including the chondrocranium
(CC), gill arch cartilages (C), and nasal cartilages (NC). Expression
is also seen in the cartilaginous components and/or muscles of the
oral (OM) and tail (TM) musculature where there is overlap of
EGFP and DsRed signals (yellow). The position of the brain is indi-
cated by a white dotted line. The specimen was rotated on its longi-
tudinal axis to expose the EGFP-rich chondrocranium that directly
underlies the brain. Auto£uorescence signals are evident in the lens
of the eye (E) and the pronephros (PN).
Fig. 5. Expression of EGFP (using the 1.73 kb fPapss2 segment) within cartilage, and muscle bundles (MB) of a maturing hindlimb obtained
from a representative stage 58 transgenic tadpole. A: Hindfoot, clearly showing the cartilaginous precursors of the digits, including an increased
level of EGFP expression corresponding to the positions of the developing interphalangeal joints. B: In the stage 58 tadpole the midregions of
the femur and tibia are encased by a developing bony sheath (also EGFP positive), whereas the ends and joints (J) of these structures are carti-
laginous with increased EGFP signals. EGFP expression is also seen in skin (S) and large muscle bundles (MB) of the hindlimb.
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tadpoles, should help in identifying these elements and tracing
their evolution from ¢shes to mammals.
Applying the relatively high-throughput method of amphib-
ian transgenesis to study the pu¡er¢sh genome has the poten-
tial to facilitate not only the rapid isolation of functional
promoter regions (and enhancers), but also the discovery of
novel and compact tissue-speci¢c gene promoters for use in
mammalian transgenic systems. In this respect, it is clear that
Fugu gene promoters can be activated and regulated in a
tissue-speci¢c manner in transgenic rodents ([6,9,10], reviewed
in [1]). Fugu gene promoter compaction not only makes the
promoters relatively easy to work with using conventional
cloning techniques, but also implies that these promoters
may be able to function independently despite their close
proximity to one another. Thus, it may be technically feasible
to generate individual transgene constructs in which two or
more gene products are placed under the control of di¡erent
Fugu promoters. This would allow, for example, in vivo stud-
ies of gene^gene interaction across di¡erent tissues, or be-
tween cell types within a given tissue, via the use of a single
transgene. Such an approach would obviate the need for the
time-consuming breeding strategies that are typically neces-
sary when combinations of di¡erent transgenes are contem-
plated.
Lastly, this study provides an example of how the pu¡er¢sh
genome allows one to initiate a promoter analysis study using
the entire intergenic region as the departure point, an ap-
proach that is rarely feasible with the genomes of other or-
ganisms. As 5P regulatory elements may be widely dispersed in
typical genomes, the compact nature of Fugu intergenic re-
gions may well prove critical when evaluating new transgene
promoters for their ability to obey the developmental cues
responsible for regulating tissue- and di¡erentiation stage-spe-
ci¢c gene function.
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